Reaction
Cellulitis Staphylococcal reporting signals
As of the last recalculation, Cellulitis Staphylococcal appears in 645 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is CANAKINUMAB (PRR 74.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canakinumab | 24 | 74.3 | 74.5 |
| Busulfan | 26 | 55.5 | 55.6 |
| Anakinra | 24 | 48.5 | 48.5 |
| Alemtuzumab | 26 | 45.2 | 45.2 |
| Indomethacin | 17 | 42.5 | 42.5 |
| Thalidomide | 30 | 27.6 | 27.6 |
| Fludarabine Phosphate | 30 | 25.8 | 25.8 |
| Etonogestrel | 8 | 5.5 | 5.5 |